BiotechTube
Home/Pipeline/Prostate cancer 'super test'

Prostate cancer 'super test'

Prostate Cancer

DevelopmentActive

Key Facts

Indication
Prostate Cancer
Phase
Development
Status
Active
Company
EDX Medical

About EDX Medical

EDX Medical is a UK-listed diagnostics company founded in 2019, specializing in precision testing for cancer, cardiovascular, and infectious diseases. Its strategy is built on a hybrid model of in-house development and strategic partnerships, notably with Caris Life Sciences and Thermo Fisher Scientific, to distribute and co-develop advanced molecular profiling and functional assays. The company is transitioning from a distributor to a developer, with a pipeline of novel tests and a planned launch of an advanced bowel cancer service in 2026, positioning itself at the intersection of digital and laboratory-based diagnostics.

View full company profile

Therapeutic Areas

OncologyCardiovascular diseasesInfectious Diseases

Other Prostate Cancer Drugs

DrugCompanyPhase
APVO442Aptevo TherapeuticsPreclinical
APVO452Aptevo TherapeuticsDiscovery
BIO 300Humanetics Corp.Not Specified
OpaganibRedHill BiopharmaPhase 2
MagSense™ PSMA Imaging AgentImagion BiosystemsPre‑clinical
Small-Molecule TherapeuticAIkido LabsPre-clinical
LeronlimabCytoDynPreclinical
CROES RegistryAngioDynamicsPost-Market Registry
Cannabics® PRST-33CNBX PharmaceuticalsDiscovery
HDP-103Heidelberg PharmaPreclinical
ENV105Kairos PharmaPhase 2
AI for Prostate CancerInvenio ImagingResearch